“MOLECULAR DOCKING STUDY OF QUINOLIN-4(1H)-ONE DERIVATIVES AS VEGFR-2 INHIBITORS FOR THE TREATMENT OF LUNG CANCER”. Frontier in Medical and Health Research, vol. 3, no. 6, Aug. 2025, pp. 1-15, https://fmhr.net/index.php/fmhr/article/view/712.